Get the Daily Brief
Latest Biotech News
AI in Battery and Energy Storage Management
Innovations integrating artificial intelligence and advanced materials have significantly improved lithium-ion battery performance and longevity prediction. Researchers have developed hybrid deep...
HHS ends mRNA vaccine funding amid scientific backlash
The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., has terminated nearly $500 million in contracts dedicated to developing mRNA vaccines for infectious...
Strand Therapeutics raises $153M for programmable mRNA cancer drugs
Strand Therapeutics, a Cambridge-based biotech specializing in programmable mRNA therapies designed to activate immune responses against solid tumors, secured a $153 million Series B financing....
Eli Lilly's oral GLP-1 obesity pill underperforms rivals in phase 3 trial
Eli Lilly reported top-line results from the Attain-1 phase 3 trial of orforglipron, its oral GLP-1 receptor agonist for obesity treatment. The highest dose resulted in an average weight loss of...
10x Genomics acquires Scale Biosciences to scale single-cell tech
10x Genomics announced its acquisition of Scale Biosciences, a company specializing in instrumentation-free, high-throughput combinatorial barcoding technologies for single-cell analysis. The...
Major biopharma financings highlight investment trends
Several biopharma companies have announced significant funding rounds and financings amid an otherwise downturn in sector-wide investment activity. Notable deals include Frazier Life Sciences...
Pediatric and neonatal care innovations advance with new diagnostics and therapies
Pediatric and neonatal medicine have seen critical advances ranging from novel imaging technologies to therapeutic regimens. Notable developments include Boston Children’s Hospital, Dana-Farber,...
Cancer drug developments and clinical trials show promising progress
Recent oncology updates reveal a dynamic landscape of drug development and clinical trial advances. Highlights include AbbVie and Genmab’s Phase 3 success for the T cell engager Epkinly in...
Advances in battery and energy storage technologies push performance frontiers
Cutting-edge research in battery sciences and energy storage is marking significant progress. Innovations include deep eutectic electrolyte use to stabilize aluminum anodes, bimetallic doping...
Neuroscience research unveils new insights into brain development and neurodegeneration
Recent neuroscience studies investigate fundamental mechanisms in brain development and neurodegenerative diseases. Breakthroughs include microglia’s regulation of prenatal neurogenesis via IGF1...
mRNA vaccine funding cuts: National security concerns rise
The U.S. Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy Jr., has abruptly terminated nearly $500 million in contracts supporting 22 mRNA vaccine development...
Obesity drug market heats up amid trial results and competition
Recent data highlight a complex competitive landscape in anti-obesity pharmaceuticals. Eli Lilly’s oral GLP-1 agonist orforglipron reported weight loss around 11% after 72 weeks, falling short of...
Single-cell genomics scale-up: 10x Genomics acquires Scale Biosciences
10x Genomics announced the acquisition of Scale Biosciences for $30 million upfront plus milestones, aiming to advance its Chromium single-cell platform through innovative combinatorial indexing...
Advancements in pediatric cancer genomics and diagnostics
Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have launched BrightSeq, a collaborative clinical research consortium providing integrated tissue and liquid...
Novel protein evolution platform accelerates therapeutic discovery
Researchers at Scripps Research have developed T7-ORACLE, a synthetic biology platform capable of accelerating protein evolution by thousands of times natural rates. This 'evolution engine'...
Advances and challenges in cancer immunotherapy and targeted therapies
Recent developments highlight progress in cancer immunotherapy, including Genmab and AbbVie’s Epkinly demonstrating positive Phase 3 results for follicular lymphoma, potentially enabling earlier...
Biotech financing and strategic industry shifts amid market volatility
Despite a biotech funding environment marked by declines and uncertainty, several companies have successfully raised capital to fuel innovation. Frazier Life Sciences secured $1.3 billion in its...
Innovations in neurodegenerative disease research and therapies
Groundbreaking research reveals lithium deficiency in human and mouse brains as a contributing factor to the onset and progression of Alzheimer’s disease. Amyloid plaque binding reduces lithium...
Pediatric radiology and imaging innovations improve diagnostics
Recent pediatric radiological studies have advanced knowledge across diverse conditions. Innovations include MRI-guided hydrostatic reduction for intussusception, reduced sedation techniques with...
HHS cancels $500 million mRNA vaccine R&D contracts amid policy shift
The U.S. Department of Health and Human Services (HHS) announced termination of 22 Biomedical Advanced Research and Development Authority (BARDA) contracts totaling nearly $500 million dedicated...